Once an apparently sporadic MTC patient is reclassified as hereditary, RET genetic screening should be performed in all first-degree family members, allowing the identification of gene carriers who can thus benefit from appropriate screening, an early diagnosis and timely or prophylactic treatment measures. This evidence concerns the gene RET and medullary thyroid gland carcinoma.